Naia Pharmaceuticals, Inc.

Industry

  • Biotechnology
    • Large Molecule
    • Drug Discovery Technologies
      • ADMET
  • Pharmaceuticals

Other Names/Subsidiaries

  • 9 Meters Biopharma, Inc.
  • Innovate Biopharmaceuticals, Inc.
  • Naia Metabolic
  • Naia Rare Diseases, Inc.
  • RDD Pharma Ltd
See more in Biomedtracker

Latest on Naia Pharmaceuticals, Inc.

Scrip

The NASH Pipeline: Replete With Targets And New Compounds

 
• By John Davis

Many targets and drugs are being evaluated for the treatment of non-alcoholic steatohepatitis (NASH), a form of non-alcoholic fatty liver disease (NAFLD), but no one really knows which will turn out b

Scrip

Start-Up Execs On The Move, May 2015

 
• By Regina Paleski

Start-Up Execs Allena Pharmaceuticals Inc. Louis Brenner, MD To: COO (April) From: SVP, CMO, Idera Pharmaceuticals Phone: 215-791-0105 Aimmune Therapeutics Inc. Mary Rozenman, PhD To: SVP,

Scrip

Start-Up Quarterly Statistics, Q1 2015

 
• By Deanna Kamienski

Financings During the first quarter of 2015, start-up companies raised a total of $2.74 billion, the third quarter in a row in which the record has been broken. (Last quarter’s total was $1.46 billion

Scrip

Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks

 
• By Melanie Senior

Type 2 diabetes isn’t an obvious spot for any aspiring biotech entrepreneur to invest hard-raised dollars. The highly competitive marketplace is dominated by Sanofi , desperate as $7 billion Lantu